{"id":"https://openalex.org/W3177490331","doi":"https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.16","title":"A Novel Inhibitor that Targets both p53\u2010Dependent Apoptotic and Autophagy Pathways as a Pancreatic Cancer Therapeutic","display_name":"A Novel Inhibitor that Targets both p53\u2010Dependent Apoptotic and Autophagy Pathways as a Pancreatic Cancer Therapeutic","publication_year":2018,"publication_date":"2018-04-01","ids":{"openalex":"https://openalex.org/W3177490331","doi":"https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.16","mag":"3177490331"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.2018.32.1_supplement.836.16","doi":"https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.16","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.16","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101471919","display_name":"Jiongjia Cheng","orcid":"https://orcid.org/0000-0002-0908-3880","observed_orcids":["https://orcid.org/0000-0002-0908-3880"]},"institutions":[{"id":"https://openalex.org/I4210101924","display_name":"ChemRegen (United States)","ror":"https://ror.org/01abfef94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101924"]},{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiongjia Cheng","raw_affiliation_strings":["ChemRegen Inc., San Diego, CA","Human BioMolecular Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemRegen Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210101924"]},{"raw_affiliation_string":"Human BioMolecular Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4210110847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100422961","display_name":"Donghoon Lee","orcid":"https://orcid.org/0000-0001-5220-3991","observed_orcids":["https://orcid.org/0000-0001-5220-3991","https://orcid.org/0009-0005-0321-4682"]},"institutions":[{"id":"https://openalex.org/I4210101924","display_name":"ChemRegen (United States)","ror":"https://ror.org/01abfef94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101924"]},{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong\u2010Hoon Lee","raw_affiliation_strings":["ChemRegen Inc., San Diego, CA","Human BioMolecular Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemRegen Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210101924"]},{"raw_affiliation_string":"Human BioMolecular Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4210110847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046215725","display_name":"Karl J. Okolotowicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101924","display_name":"ChemRegen (United States)","ror":"https://ror.org/01abfef94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101924"]},{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl J. Okolotowicz","raw_affiliation_strings":["ChemRegen Inc., San Diego, CA","Human BioMolecular Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemRegen Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210101924"]},{"raw_affiliation_string":"Human BioMolecular Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4210110847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089839809","display_name":"Andrew M. Lowy","orcid":"https://orcid.org/0000-0002-7106-0735","observed_orcids":["https://orcid.org/0000-0002-7106-0735"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew M. Lowy","raw_affiliation_strings":["Department of Surgery, Division of Surgical Oncology, University of California at San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of Surgical Oncology, University of California at San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028469156","display_name":"John Richard Cashman","orcid":"https://orcid.org/0000-0002-8628-9129","observed_orcids":["https://orcid.org/0000-0002-8628-9129"]},"institutions":[{"id":"https://openalex.org/I4210101924","display_name":"ChemRegen (United States)","ror":"https://ror.org/01abfef94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101924"]},{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John R. Cashman","raw_affiliation_strings":["ChemRegen Inc., San Diego, CA","Human BioMolecular Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemRegen Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210101924"]},{"raw_affiliation_string":"Human BioMolecular Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4210110847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33106199,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.61080002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.61080002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.31349998712539673,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8450000286102295},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.527999997138977},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.996999979019165},{"id":"https://openalex.org/keywords/dna-damage-checkpoint","display_name":"DNA damage checkpoint","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cytochrome-c-release","display_name":"cytochrome c release","score":0.8339999914169312},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.7860000133514404},{"id":"https://openalex.org/keywords/parp-cleavage","display_name":"PARP cleavage","score":0.7749999761581421},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.640999972820282},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9829999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7940824031829834},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7519694566726685},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6877998113632202},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6329282522201538},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6111884117126465},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.576075553894043},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4706615209579468},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46579134464263916},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.45650535821914673},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4280162453651428},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41205552220344543},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36577165126800537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3039321303367615},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2553494870662689},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.2018.32.1_supplement.836.16","doi":"https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.16","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2018.32.1_supplement.836.16","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3638359613","display_name":"Novel Small Molecule Therapeutics for Pancreatic Cancer","funder_award_id":"1r41ca176931-01a1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4941414813","display_name":"RON Receptor in Pancreatic Cancer Biology and Therapy","funder_award_id":"R01CA155620","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2081775759","https://openalex.org/W4389008333","https://openalex.org/W1492231491","https://openalex.org/W2988016252","https://openalex.org/W1716112043","https://openalex.org/W4220904273","https://openalex.org/W2886160624","https://openalex.org/W3212649507","https://openalex.org/W2314570919","https://openalex.org/W2884803754"],"abstract_inverted_index":{"In":[0,168],"the":[1,13,23,204,220,263,282,290,311,321,370,435,444],"United":[2],"States,":[3],"by":[4,176,261,420,432],"2030,":[5],"pancreatic":[6,28,36],"cancer":[7],"(PC)":[8],"is":[9,130,363,369,442,450],"predicted":[10],"to":[11,41,64,87,108,191,249,333,341,392,405],"be":[12],"second":[14],"most":[15],"common":[16],"cause":[17],"of":[18,27,34,43,71,92,206,208,222,238,252,266,275,284,292,323,356,401,409,429],"mortality":[19],"from":[20,426,434,443],"cancer.":[21],"Today,":[22],"5\u2010year":[24],"survival":[25],"rate":[26],"ductal":[29],"adenocarcinoma":[30],"(PDAC,":[31],"comprising":[32],">90%":[33],"all":[35],"cancers)":[37],"remains":[38],"<5%":[39],"due":[40],"lack":[42],"early":[44],"detection":[45],"and":[46,122,140,147,227,281,298,301,304,325,327,331,365,382,397,423,431],"poor":[47,75],"treatment":[48,98],"prognosis.":[49],"The":[50,461],"transcription":[51],"factor":[52],"(i.e.,":[53,102,152,230,278,351],"tumor":[54,118,172,187],"suppressor":[55,119],"gene":[56],"p53)":[57],"has":[58,389],"been":[59],"well\u2010characterized":[60],"for":[61,99],"its":[62],"susceptibility":[63],"genetic":[65],"or":[66,198,413],"epigenetic":[67],"modifications.":[68],"About":[69],"75%":[70],"PC":[72,84,93,115,125,402],"patients":[73,94],"with":[74,104,164,241,456],"clinical":[76],"prognosis":[77],"have":[78],"intragenic":[79],"p53":[80,360],"mutations":[81],"that":[82,112,374,403],"makes":[83],"cells":[85,126,151,240,377],"resistant":[86],"chemotherapeutic":[88],"regimens.":[89],"A":[90,110],"majority":[91],"rely":[95],"on":[96,219],"combination":[97,163],"better":[100],"outcomes":[101],"gemcitabine":[103,165],"nab\u2010paclitaxel)":[105],"in":[106,162,223,287,320,358,460],"addition":[107],"surgery.":[109],"drug":[111],"potently":[113,135,211],"inhibits":[114],"growth,":[116],"restores":[117],"function,":[120],"sensitizes":[121],"powerfully":[123],"drives":[124],"towards":[127,270],"cell":[128,137,306,343,384,399],"death":[129,138,344,385,400],"urgently":[131],"needed.":[132],"Compound":[133],"1":[134,157,180,210,242,256,308,362,387,410],"modulated":[136],"checkpoints":[139],"was":[141,349,418],"highly":[142],"efficacious":[143],"against":[144],"both":[145,329],"WT":[146],"mutant":[148],"p53\u2010bearing":[149],"PDAC":[150,171,213,239,376],"HPAC,":[153],"MIA":[154],"PaCa\u20102,":[155],"AsPC\u20101).":[156],"also":[158,309,388],"showed":[159],"synergistic":[160],"potency":[161,408],"and/or":[166],"paclitaxel.":[167],"an":[169],"invasive":[170],"model":[173],"(LM\u2010P,":[174],"developed":[175],"Dr.":[177],"Andy":[178],"Lowy),":[179],"(20":[181],"mg/kg/day,":[182],"28":[183],"days,":[184],"i.p.)":[185],"inhibited":[186,212],"growth":[188],"65%":[189],"compared":[190],"vehicle\u2010treated":[192],"mice":[193],"without":[194],"any":[195],"apparent":[196],"acute":[197],"chronic":[199],"toxicity.":[200],"Herein,":[201],"we":[202],"report":[203],"mechanism":[205,228],"action":[207],"1.":[209],"via":[214,378],"dual":[215,390],"signaling":[216,246],"pathways":[217],"based":[218],"results":[221],"vitro":[224],"molecular":[225],"target":[226],"validation":[229],"qPCR,":[231],"subcellular":[232],"fractionation,":[233],"immunoblot,":[234],"immunoprecipitation,":[235],"etc.).":[236],"Treatment":[237],"activated":[243,258,299],"mitotic":[244],"stress":[245],"including":[247],"ATM/ATR\u2010kinase":[248],"induce":[250,342,393],"activation":[251,274,348],"DNA":[253],"damage":[254],"checkpoints.":[255],"further":[257],"cytosolic":[259],"p53/Bax":[260],"inhibiting":[262],"antagonizing":[264],"effect":[265],"Bcl\u20102/Bcl\u2010xL":[267,326],"(anti\u2010apoptotic":[268],"proteins)":[269],"p53/Bax.":[271],"This":[272,337,416,440],"caused":[273],"pro\u2010apoptotic":[276],"markers":[277,286],"Bak,":[279],"Bax)":[280],"accumulation":[283],"those":[285],"mitochondria,":[288],"induced":[289],"release":[291],"mitochondrial":[293],"cytochrome":[294],"c":[295],"into":[296],"cytosol":[297],"caspase":[300],"PARP":[302],"cleavage,":[303],"triggered":[305],"apoptosis.":[307],"enhanced":[310],"interaction":[312],"between":[313,395],"Beclin\u20101":[314],"(Beclin\u20101":[315],"plays":[316],"a":[317],"critical":[318],"role":[319],"regulation":[322],"autophagy)":[324],"increased":[328],"LC3\u2010II":[330],"p62":[332],"impair":[334],"lysosomal":[335],"function.":[336],"repressed":[338],"late\u2010stage":[339,355],"autophagy":[340],"when":[345],"apoptotic":[346,381,396],"pathway":[347],"deficient":[350],"under":[352],"starvation":[353],"conditions,":[354],"treatment,":[357],"null":[359],"cells).":[361],"unique":[364],"innovative":[366],"because":[367],"it":[368],"only":[371],"known":[372],"compound":[373],"kills":[375],"differentially":[379],"modulating":[380],"autophagic":[383,398],"pathways.":[386],"properties":[391],"crosstalk":[394],"contributes":[404],"potent":[406],"anti\u2010PC":[407],".":[411,464],"Support":[412],"Funding":[414],"Information":[415],"work":[417],"supported":[419],"1R41CA176931\u201001A1":[421],"(KJO)":[422],"1RO1CA155620\u201001":[424],"(AML)":[425],"National":[427],"Institutes":[428],"Health":[430],"funds":[433],"Human":[436],"BioMolecular":[437],"Research":[438],"Institute.":[439],"abstract":[441,458],"Experimental":[445],"Biology":[446],"2018":[447],"Meeting.":[448],"There":[449],"no":[451],"full":[452],"text":[453],"article":[454],"associated":[455],"this":[457],"published":[459],"FASEB":[462],"Journal":[463]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-07-05T00:00:00"}